A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer.

Autor: Du Y; The Second School of Clinical Medicine, Lanzhou University, Lanzhou 730030, China., Jiang W; The Second School of Clinical Medicine, Lanzhou University, Lanzhou 730030, China., Hou S; The Second School of Clinical Medicine, Lanzhou University, Lanzhou 730030, China., Chen Z; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730030, China., Zhou W; The Second School of Clinical Medicine, Lanzhou University, Lanzhou 730030, China.; Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
Jazyk: angličtina
Zdroj: BioMed research international [Biomed Res Int] 2023 Jan 18; Vol. 2023, pp. 3419401. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
DOI: 10.1155/2023/3419401
Abstrakt: Background: Pancreatic cancer (PAAD) is a malignant tumor with a poor prognosis and lacks sensitive biomarkers for diagnosis and targeted therapy. Cuproptosis, a recently proposed form of cell death based on cellular copper ion concentration, plays a key role in cancer biology. This study is aimed at constructing a risk model for predicting the prognosis of PAAD patients based on cuproptosis-related genes.
Methods: Pancreatic-related data from UCSC-TCGA and UCSC-GTEx databases were extracted for analysis, and TCGA-PAAD samples were randomly divided into the training and validation groups. Pearson correlation analysis was used to obtain cuproptosis-related genes coexpressed with 19 copper death genes. Univariate Cox and Lasso regression analyses were used to obtain cuproptosis-related prognostic genes. Multivariate Cox regression analysis was used to construct the final prognostic risk model. The risk score curve, Kaplan-Meier survival curves, and ROC curve were used to evaluate the predictive ability of the Cox risk model. Finally, the functional annotation of the risk model was obtained through enrichment analysis.
Results: The Cox risk model has an eight prognostic cuproptosis-related gene signature. Kaplan-Meier survival curves demonstrated that the high-risk group had a shorter survival time. The ROC curve of the risk score was well created to predict one-, three-, and five-year survival rates, and AUC of the risk score was higher than other clinical characteristics. Cox regression analysis revealed that the risk score has an independent prognostic value for PAAD. GSEA reveals specific tumor pathways associated with the risk model (Myc targets v1, mTORC1 signaling, and E2F targets).
Conclusions: We constructed a prognostic model containing eight cuproptosis-related genes (AKR1B10, KLHL29, PROM2, PIP5K1C, KIF18B, AMIGO2, MRPL3, and PI4KB) that can accurately predict the prognosis of PAAD patients. The results will provide new perspectives for individualized outcome prediction and new therapy development for PAAD patients.
Competing Interests: All authors declare that there is no conflict of interest.
(Copyright © 2023 Yan Du et al.)
Databáze: MEDLINE
Externí odkaz: